Q:What are the uses and benefits of Tributyl phosphate?
A:Tributyl phosphate (TBP) is a widespread extracting agent generally used in processing transuranium elements and removing them from wastewaters of the nuclear industry.
Jan 26,2024 APITisotumab Vedotin: Synthesis and Introduction
Tisotumab Vedotin may be obtained by conjugating Vedotin to a TF monoclonal antibody.
Jan 26,2024 Biochemical EngineeringAsciminib Hydrochloride: Synthesis and Introduction
Asciminib Hydrochloride is synthesised using chloronicotinate as a raw material by chemical reaction.
Jan 26,2024 Biochemical EngineeringHow is Piflufolastat F-18 synthesised?
Piflufolastat F-18 is synthesised from Trimethylammonium Salt and Activated Ester through a series of chemical reactions.
Jan 26,2024 DrugsHow is Sotorasib synthesised?
The synthetic route of Sotorasib is completed in three steps, starting with the amidation of nicotinic acid derivatives to produce nicotinamide, obtaining acyl isomer purity 28.6 by classical resoluti
Jan 26,2024 InhibitorsWhat is the flame colour of rubidium?
Rubidium is a soft, silvery-white metallic element of the alkali metals group (Group 1). It is one of the most electropositive and alkaline elements. Its flame is yellowish-violet.
Jan 26,2024 Inorganic chemistrySodium Stearyl Fumarate: An Essential Lubricant in Solid Dosage Forms with Safety Considerations
Sodium Stearyl Fumarate is a widely used lubricant in solid dosage forms, but caution is needed due to potential incompatibility issues and the need for proper handling.
Jan 26,2024 APIDimethomorph: Pharmacokinetics, Mammalian Toxicity and Ecotoxicology
Dimethomorph is readily absorbed, rapidly metabolized, and efficiently eliminated from the body, showing low toxicity to mammals but adverse effects on liver and testes, with low ecotoxicity risks.
Jan 26,2024 APIPiroxicam: Pharmacokinetics, Mechanism of Action and Toxicology Studies
Piroxicam, a nonsteroidal anti-inflammatory drug with linear pharmacokinetics and a half-life of 30 to 60 hours, inhibits prostaglandin synthesis. High doses cause adverse pregnancy outcomes.
Jan 26,2024 APIBaloxavir Marboxil: A Cap-Dependent Endonuclease Inhibitor for the Treatment of Influenza
Baloxavir marboxil is a novel influenza treatment with single-dose administration, inhibiting viral gene transcription. Further research needed for efficacy and safety outside 48-hour window.
Jan 26,2024 API